The loss of the tumour-suppressor miR-145 results in the shorter disease-free survival of prostate cancer patients

BACKGROUND: Prostate cancer (PCa) is characterised by great heterogeneity of the disease progression rate. Tumours range from insignificant and not life threatening to high risk for relapse ones. Consequently, a large number of patients undergo unnecessary treatment. miR-145 is a well-documented tum...

Descripción completa

Detalles Bibliográficos
Autores principales: Avgeris, M, Stravodimos, K, Fragoulis, E G, Scorilas, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694240/
https://www.ncbi.nlm.nih.gov/pubmed/23703249
http://dx.doi.org/10.1038/bjc.2013.250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694240/
https://www.ncbi.nlm.nih.gov/pubmed/23703249
http://dx.doi.org/10.1038/bjc.2013.250

Ejemplares similares